Effects of zero-balanced ultrafiltration on procalcitonin and respiratory function after cardiopulmonarv bypass

Perfusion

Volumn 22, Issue 5, 2007, Pages 339-343

  Lou, Song ^a   Liu, Yinglong ^a   Liu, Jinping ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FALLOT TETRALOGY; HUMAN; INFANT; INFLAMMATION; INTUBATION; LUNG COMPLIANCE; LUNG DISEASE; LUNG FUNCTION; MEDIATOR; OPEN HEART SURGERY; OXYGENATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; STATISTICAL SIGNIFICANCE; ULTRAFILTRATION; WARMING; ZERO BALANCED ULTRAFILTRATION;

BIOLOGICAL MARKERS; CALCITONIN; CARDIOPULMONARY BYPASS; HUMANS; INFANT; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; TETRALOGY OF FALLOT; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 42049092762     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659107086726     Document Type: Article

References (10)

1. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112(3): 676-87.
2. Journois D, Israel-Biet D, Pouard P, et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996; 85: 965-76.
3. Huang H, Yao T, Wang W, et al. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg 2003; Jul, 76(1): 136-40.
4. Darling E, Searles B, Nasrallah F, et al. High-volume, zero-balanced ultrafiltration improves pulmonary function in a model of post-pump syndrome. JECT 2002; 34: 254-59.
5. Hensel M, Volk T, Döcke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass [Clinical Investigations]. Anesthesiology 1998 Jul; 89(1): 93-104.
6. Level C, Chauveau P, Guisset O. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 2003 Dec; 7(6): R160-66.
7. Tallman RD, Dumond M, Brown D. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass. Perfusion 2002 Mar; 17(2): 111-15.
8. Chew MS, Brix-Christensen V, Ravn HB, et al. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study. Perfusion, 2002 Sep; 17(5): 327-33.
9. Whang KT, Vath SD, Becker KL, et al. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 2000 Jul; 14(1): 73-8.
10. Michalik DE, Duncan BW, Mee RB, et al. Quantitative analysis of procalcitonin after pediatric cardiothoracic surgery. Cardiol Young 2006 Feb; 16(1): 48-53.